Search results - 14 results
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative
transforming oncology, but challenges such as insufficient analytical sensitivity, difficult variant interpretation, suboptimal turnaround time, limited deployment flexibility, and high costs hinder its broader ...
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
Publication Type: Peer reviewed scientific article Authors: Pui Yan Jenny Chung; Sharon Dhillon; Cindy Simoens; Lize Cuypers; Lies Laenen; Bonde, Jesper; Philippe Corbisier; Gerhard Buttinger; Clementina E Cocuzza; Steven Van Gucht; Marc Van Ranst; M. Arb ...
Validation of the Flemish-Dutch Lower Extremity Functional Scale (LEFS) questionnaire for diabetic foot ulcers
visual analytical scale (p<0.0001). The LEFS score was not sensitive to ulcer changes over time. Conclusions: The Flemish-Dutch version of the LEFS questionnaire has good reliability properties and ...
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.
of SARS-CoV-2 assays receiving emergency authorization that lacked robust analytical or clinical evaluation. As it is highly likely that testing for SARS-CoV-2 will continue to play a central role in ...
Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.
used for rare diseases and a survey addressed to the Belgian laboratories of clinical pathology (investigating the annual analytical costs, volumes, turnaround times and the tests unavailable in Belgium ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
HPV assays with genotyping capability. In VALGENT-3, the clinical and analytical performance of Anyplex II HPV HR detection (Anyplex) was compared to that of the Hybrid Capture 2 HPV DNA test (hc2) and ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
VALGENT is designed to assess the analytical and clinical performance of HPV tests with genotyping capacity. The VALGENT-3 panel comprised 1300 consecutive cervical cell specimens enriched with 300 samples ...
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).
(VALGENT) studies offer an opportunity to clinically validate HPV assays for use in primary screening for cervical cancer and also provide a framework for the comparison of analytical and type-specific ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
Publication Type: Peer reviewed scientific article Authors: Heard, I; Cuschieri, K; Geraets, D T; Quint, W; M. Arbyn Source: J Clin Virol, Volume 81, p.6-11 (2016) Abstract: BACKGROUND: The benefit of HPV testing for cervical cancer screening and disease ...
Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples.
Analytically accurate human papillomavirus (HPV) genotyping methods are required to assess the impact of HPV vaccination. The aim of this study was to evaluate the analytical performance of Anyplex II HPV28 ...